Table 1 Inhibitory zone diameter and MIC of the biosynthesized AgNPs (p < 0.05).

From: Biosynthesis of silver nanoparticles by Talaromyces funiculosus for therapeutic applications and safety evaluation

Microorganisms

Inhibition zone diameter in mm

MIC (µg/mL)

Positive control

Fungal filtrate

AgNO₃ (10 µg/mL)

AgNPs (µg/mL)

5

10

25

50

Gram-negative bacteria

E. coli

11.7 ± 0.3

Ampicillin (10 µg)/mL)

12.3 ± 0.3

14.7 ± 0.3

21.0 ± 1.0

26.3 ± 0.6

3.7 ± 0.3

P. aeruginosa

7.3 ± 0.3

7.7 ± 0.3

12.7 ± 0.3

16.3 ± 0.3

5.7 ± 0.3

Gram-positive bacteria

B. cereus

8.7 ± 0.3

12.3 ± 0.3

15.0 ± 1.0

17.3 ± 0.3

23.0 ± 1.0

4.3 ± 0.3

S. aureus

12.3 ± 0.3

9.0 ± 1.0

12.7 ± 0.3

17.3 ± 0.3

22.0 ± 1.0

4.7 ± 0.3

Yeast species

C. albicans

-

Fluconazole (25 µg/mL)

8.0 ± 1.0

12.3 ± 0.3

16.0 ± 1.0

7.3 ± 0.3

C. tropicalis

8.7 ± 1.0

8.0 ± 0

14.3 ± 0.3

22.3 ± 0.3

6.3 ± 0.3

G. candidum

-

11.7 ± 0.3

14.7 ± 0.3

13.3 ± 0.3